Northern Trust’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,051
Closed -$24.3K 4461
2024
Q2
$24.3K Sell
4,051
-16
-0.4% -$84 ﹤0.01% 4312
2024
Q1
$33.4K Buy
4,067
+155
+4% +$828 ﹤0.01% 4283
2023
Q4
$19.6K Sell
3,912
-211
-5% -$1.35K ﹤0.01% 4367
2023
Q3
$25.6K Hold
4,123
﹤0.01% 4287
2023
Q2
$57.3K Hold
4,123
﹤0.01% 4188
2023
Q1
$48.6K Buy
4,123
+500
+14% +$9.39K ﹤0.01% 4278
2022
Q4
$70.6K Hold
3,623
﹤0.01% 4199
2022
Q3
$51K Hold
3,623
﹤0.01% 4318
2022
Q2
$88K Sell
3,623
-240
-6% -$6.68K ﹤0.01% 4222
2022
Q1
$134K Hold
3,863
﹤0.01% 4259
2021
Q4
$111K Hold
3,863
﹤0.01% 4391
2021
Q3
$191K Sell
3,863
-102
-3% -$5.12K ﹤0.01% 4202
2021
Q2
$201K Sell
3,965
-15,117
-79% -$761K ﹤0.01% 4167
2021
Q1
$1.09M Sell
19,082
-943
-5% -$61.4K ﹤0.01% 3553
2020
Q4
$901K Buy
20,025
+132
+0.7% +$6.36K ﹤0.01% 3551
2020
Q3
$1M Sell
19,893
-424
-2% -$23K ﹤0.01% 3398
2020
Q2
$1.24M Buy
20,317
+18,675
+1,137% +$1.13M ﹤0.01% 3278
2020
Q1
$62K Hold
1,642
﹤0.01% 3920
2019
Q4
$76K Buy
1,642
+234
+17% +$7.8K ﹤0.01% 3987
2019
Q3
$63K Sell
1,408
-110
-7% -$4.91K ﹤0.01% 4019
2019
Q2
$68K Hold
1,518
﹤0.01% 4032
2019
Q1
$81K Buy
1,518
+13
+0.9% +$649 ﹤0.01% 3963
2018
Q4
$70K Buy
+1,505
New +$86.4K ﹤0.01% 3989

Other funds holding ORGS

Northern Trust's ORGS Position: Q3 2024 in Review

Northern Trust sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2024, closing a stake of 4,051 shares — an estimated $24.3K sold.

Northern Trust first reported a position in ORGS in Q4 2018 and held it in 23 quarters. The position peaked at $1.24M in Q2 2020. 11 funds tracked by Wall St. Rank hold ORGS as of Q3 2024.

  • Northern Trust reported no remaining Orgenesis Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Northern Trust sold 4,051 Orgenesis Inc. Common Stock shares in Q3 2024, an estimated $24.3K.
  • Northern Trust first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 23 quarters.
  • Northern Trust's Orgenesis Inc. Common Stock position peaked at $1.24M in Q2 2020.
  • 11 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.